Background: Societal preference-weighted health-related quality of life (HRQOL) scores enable comparing multidimensional health states across diseases and treatments for research and policy. Objective: To assess the effects of living with a permanent intestinal stoma, compared with a major bowel resection, among colorectal cancer (CRC) survivors. Research Design: Cross-sectional multivariate linear regression analysis to explain preference-weighted HRQOL scores. Subjects: In all, 640 CRC survivors (Ն5 years) from 3 group model health maintenance organizations; ostomates and nonostomates with colorectal resections for CRC were matched on gender, age (Ϯ5 years), time since diagnosis, and tumor site (rectum vs. colon). Measures: SF-6D scoring system was applied to Medical Outcomes Study Short Form-36 version 2 (SF-36v2); City of Hope Quality of Life-Ostomy; and Charlson-Deyo comorbidity index. Methods: Survey of CRC survivors linked to respondents' clinical data extracted from health maintenance organization files. Results: Response rate was 52%. Ostomates and nonostomates had similar sociodemographic characteristics. Mean SF-6D score was 0.69 for ostomates, compared with 0.73 for nonostomates (P Ͻ 0.001), but other factors explained this difference. Complications of initial cancer surgery, and previous year comorbidity burden, and hospital use were negatively associated with SF-6D scores, whereas household income was positively associated. Conclusions: CRC survivors' SF-6D scores were not associated with living with a permanent ostomy after other factors were taken into account. Surgical complications, comorbidities, and metastatic disease lowered the preference-weighted HRQOL of CRC survivors with and without ostomies. Further research to understand and reduce late complications from CRC surgeries as well as associated depression is warranted.
C olorectal cancer (CRC) is the third most common cancer in the United States (excluding skin cancer) and the third leading cause of cancer deaths. Approximately 147,000 new CRC cases were diagnosed in 2008. 1 Although surgery is highly effective, it often involves changes to bowel functioning, including loss of control with soiling. This may occur whether the patient has a resection with permanent intestinal stoma (ostomy) or an anastomosis. Many patients refuse or delay CRC surgery for fear of living with an ostomy, 2,3 even at the risk of on-going medical problems and cancer progression that will ultimately bring about their demise. An ostomy has pervasive effects on everyday life-wearing an ostomy bag underneath one's clothing, possibility of repeated skin irritations, difficulties with diet selection and bowel control, as well as reduced social, emotional, sexual, and occupational functioning-that combine to reduce overall functioning and quality of life. 4 -7 Our research has shown that ostomies are associated with substantially poorer health-related quality of life (HRQOL) among CRC survivors. 6 -8 Despite their importance, economic evaluations of the long-term and late effects of surgical procedures for primary cancer among CRC survivors have not been extensively explored. Our primary aim was to examine the determinants of societal preferenceweighted HRQOL, as measured by the Short Form (SF)-6D, 9 -11 among CRC survivors (Ն5 years) with and without permanent colostomies. We were particularly focused on whether permanent ostomies had a meaningful effect on SF-6D scores among CRC survivors relative to anastomoses.
METHODS
Methods for our HRQOL in long-term CRC survivors study are presented elsewhere. 8 This study was conducted at 3 regions of a national integrated healthcare delivery system with defined populations of CRC survivors: Kaiser Permanente Hawaii, Kaiser Permanente Northern California, and Kaiser Permanente Northwest. We made use of a crosssectional, survey research design: 679 CRC survivor respondents (284 with ostomies; 395 "nonostomates" with anastomoses) completed a mixed mode (mail or telephone) questionnaire that included HRQOL scales and sociodemographic, health, medical care utilization, and self-care items. We obtained a response rate of 52% (679/1308). Eligible participants included the following: (a) Kaiser Permanente (KP) members aged 18 years and older diagnosed with CRC between 1976 and 1999; (b) health plan members on at least the fifth anniversary of their index CRC diagnosis during 2002-2005; (c) those with an intestinal stoma or anastomosis (survivors with a previous temporary intestinal ostomy were excluded); and (d) nonostomates matched to ostomates using cancer site (coded as rectum and rectosigmoid ͓ICD-0 codes C20.0, 19.9͔ vs. colon ICD-0 codes ͓ICD-0 C18.ϫ͔); time since cancer diagnosis (within 5 years or closest possible match); age (within 5 years or closest possible match); and gender.
The survey instrument included the modified City of Hope Quality of Life-Ostomy (mCOH-QOL-O) questionnaire 12 and the SF-36 version 2 of the MOS SF-36). 9, 13, 14 Data from the multi-item scales of the mCOH-QOL-O and SF-36v2 in these study subjects are presented elsewhere. 7, 15, 16 For the analyses presented here, we used a depression item (0 ϭ "none at all" to 10 ϭ "severe") from the mCOH-QOL-Ostomy and applied the SF-6D scoring function to the SF-36v2 responses (QualityMetric Health Outcomes Scoring Software 2.0, copyright QualityMetric, Lincoln, RI, 2004 RI, -2007 .
The SF-6D score served as our dependent variable. It is a continuous variable with a possible a range from 0.29 to 1.0 on a scale where 0 indicates dead and 1.0 is perfect health. Health states between these extremes were defined by 11 items in 6 domains of the SF-36v2. Cardinal utility values were derived using visual analog scales and standard gamble techniques for a representative sample of a general population. 10, 11 SF-6D score norms for the US population range from a low of 0.75 for 85-year-old males to a high of 0.81 for 35-year-old females (standard errors ϭ 0.01). 13, 17 Walters and Brazier have provided guidance that differences of Ͼ0.033 in mean SF-6D scores are clinically important. 18 -24 Preference-weighted HRQOL scores reflect the relative desirability of health states as judged by a general population sample. Population-based preferences are seen as being most relevant for implementing public health and population-based clinical interventions.
Medical histories were obtained from KP clinical and administrative databases. From these databases, we collected type of stoma, length of time since diagnosis, site of tumor, and pre-and postoperative treatment. The Charlson-Deyo comorbidity index 25 was constructed from inpatient and outpatient ICD-9-CM codes during the year before date of survey administration. Early complications of primary CRC surgery, such as bleeding and postoperative infection, were those recorded within 30 days of the date of first CRC surgery, and were counted only once during each surgical episode. 15 Late complications were those first recorded Ͼ31 days after the primary CRC surgery and included, for example, hernia, urinary retention, hemorrhage, skin conditions around the stoma, and intestinal obstruction. 15 We estimated multivariate linear regression models to explain variation in observed SF-6D scores using Stata version 10.0 (Statacorp, College Station, TX). The study protocol and questionnaires were approved by the Institutional Review Boards at the University of Arizona, Kaiser Permanente Hawaii, Kaiser Permanente Northern California, and Kaiser Permanente Northwest.
RESULTS
Ostomates' mean SF-6D score was 0.69 as compared with 0.73 for nonostomates (P Ͻ 0.001). SF-6D score norms for comparable age groups in the general US population ranged from 0.76 to 0.80, 11, [17] [18] [19] [20] [21] [22] [23] [24] with CRC survivors having meaningfully lower SF-6D scores. Despite recruitment efforts to match on cancer location, ostomates disproportionately had more rectal cancers than nonostomates. Descriptive statistics for 284 CRC survivors with permanent ostomies ("ostomates") and 395 CRC survivors with anastomoses ("nonostomates") are shown in Table 1 . Ostomates and nonostomates did not differ at time of the survey on age, gender, race/ethnicity, follow-up years, body mass index, or the rate of chemotherapy for the initial tumor. Ostomates had more comorbid conditions (P ϭ 0.03) and were more likely to have received radiation therapy (P Ͻ 0.0001) for their initial tumor than nonostomates. Ostomates were significantly more likely to have complications at all time points after surgery, that is, within 30 days (P ϭ 0.003), between 31 and 365 days (P ϭ 0.001), and Ͼ1 year (P ϭ 0.0001) compared with nonostomate patients.
Contrary to our expectation, having a permanent ostomy was not associated with lower SF-6D scores when other determinants were included in the model ( Table 2 ). We tested for gender by ostomy interaction effects (observed in a separate analysis for certain health outcomes 7 ), but found no evidence of such interactions. Late complications of initial CRC surgery were associated with lower SF-6D scores. Having both early and late (continuing) complications appeared to be associated with even lower SF-6D scores (likelihood ratio test ͓LRT͔ of the 3 complications indicators gave a 2 of 8.15 ͓P ϭ 0.043͔). Stage was significantly associated with SF-6D scores (LRT of the 4-stage indicators gave a 2 of 10.3 ͓P ϭ 0.016͔); patients with missing staging values had significantly lower SF-6D scores as compared with patients with localized stage.
Worse self-reported depression was associated with lower SF-6D scores. Number of inpatient days and the Charlson-Deyo Comorbidity Index for the 12 months before the survey both independently contributed to lower SF-6D scores. Higher incomes were associated with higher SF-6D scores (LRT on all 5-income variables gave a 2 value of 18.55 ͓P ϭ 0.001͔), with a monotonically increasing relationship across the ordered income classes. Survivors with missing income data did not have SF-6D scores significantly different from survivors who reported annual incomes less than $30,000. Older age was associated with lower SF-6D scores. Our model explained a significant proportion of the variance in SF-6D scores (adjusted R 2 ϭ 0.36) and had a reasonably good fit to the data (F ratio ϭ 25.1 ͓P Ͻ 0.001͔). Gender, race, ethnicity, education, employment status, tumor site, chemotherapy, and radiation therapy revealed no independent associations with SF-6D scores and did not improve goodness-of-fit.
DISCUSSION
Having an ostomy was not associated with lower SF-6D scores when other relevant variables were taken into account. One possible explanation is the difference in prevalence of surgical complications in ostomates versus nonostomates: 30 to 365 days-14% versus 6%; Ͼ1 year-38% versus 23%. Nonostomates have also been reported in previous studies to have relatively high rates of bowel dysfunction. 26 Other studies conducted by this team showed that ostomy-specific problems such as fistulas, skin irritations, and leakage, predicted lower HRQOL scores among cancer survivors. 7, 27 Among patients with rectal cancer alone, complications of ostomy, but not anastomosis, were associated with reduced overall HRQOL. 15 Complications of initial CRC surgery can undermine long-term HRQOL, and more research is needed to ascertain the extent to which these interventional complications can be prevented.
Depression is a significant predictor of SF-6D scores among CRC survivors. More research is needed to identify comparatively effective screening and intervention strategies for depression among CRC survivors with multiple health problems. Previous work by mental health researchers at a large group-model health maintenance organization suggests the following: (1) giving primary care and specialist physicians a clinical depression screening tool for use in the examination room, and (2) implementing a pharmacologic treatment guideline for major clinical depression can be effective strategies to improve detection and treatment rates in the course of routine health care encounters. 28 -33 Income remains a significant predictor of SF-6D scores after adjusting for surgical treatment strategy in a population with equivalent comprehensive health insurance coverage and medical homes (ie, having a regular primary care provider, comprehensive health insurance benefits, and an integrated delivery system). This finding is consistent with another analysis performed on these data. 16 The likely direction of causation is 2-way: survivors with better health have the ability to earn higher incomes, 16 which, in turn, provides 
Limitations
The cross-sectional associations presented herein cannot be used to understand the temporal relationship between the dependent and independent variables; in addition, the observed associations could result from multiple omitted variables. Our survey response rates varied by KP region and was related to differential use of telephone follow-up to reduce missing data. CRC nonostomy survivors in Hawaii demonstrated the lowest response rate, which may also relate to cultural disparities. Another limitation relates to the known floor effects of the SF-36 (and, therefore, the SF-6D). 34 -47 Although we were able to distinguish among known groups (eg, presence vs. absence of complications of initial CRC surgery), the distribution of observed SF-6D scores may be truncated at the low end-some of the subjects were more ill than can be captured by the measure. The SF-36 works very well for subjects with mild to moderate burdens, but often understates the severity of heavier burdens. Our sample of 640 CRC survivors with complete data is a relatively small sample size to support modeling complex phenomena with highly skewed distributions-the data became relatively sparse in the most interesting population segment. Concerns about heavy response burden on older participants led us to exclude questions about medical and social history from the time of cancer diagnosis, which left a large time gap between cancer diagnosis and questionnaire administration. Our qualitative data analysis on a subsample of CRC patients clearly indicates that, for some survivors, the development of unrelated chronic illnesses and frailty associated with aging become dominant health concerns, which interact with ostomy care. 6
CONCLUSIONS AND FUTURE RESEARCH
The Institute of Medicine's report on cancer survivorship called for more research on the long-term medical and behavioral implications of living as a cancer survivor. 4 We found that CRC survivors with permanent stomas or anastomoses have clinically meaningful lower SF-6D scores as compared with the general population of the same age and gender. Living with a permanent stoma, however, is not associated with lower scores for CRC survivors when other factors are taken into account. Prior-year comorbidities and hospital use, income, age, missing stage at diagnosis, and complications from CRC surgery were associated with SF-6D scores. The higher rate of surgical complications among ostomates calls for increased attention to survivorship care planning, especially with respect to monitoring the development of long-term surgical complications. Preventing complications of initial CRC surgeries is likely to improve long-term health utility. 15, 27 Other analyses of surgical complications us- ing this data set have demonstrated that survivors with ostomies experience more long-term complications initially, but that over time long-term complication rates converge among both patient groups. 15 Future research should be designed to focus on reductions of late complications of CRC surgery, perhaps targeting those with ostomies. Finally, preference-based HRQOL measures (eg, SF-6D) are useful for surveillance of cancer survivors because health state declines are weighted by societal preferences, which in turn, can be used to guide priorities for subsequent clinical screening and intervention. Time series analyses of preference-based HRQOL scores among CRC survivors are needed to identify cause-and-effect changes.
